Anti-IDH1 (Human) mAb (Clone: RcMab-1)

MBL Life Sciences

Catalog No.: MBL-D336-3

Monoclonal antibody of 100 µl targeting IDH1 for ICC, WB.

Product Specifications

• Application: ICC, WB
• Reactivity: Human, Hamster
• Clonality: Monoclonal IgG2a ĸ
• Host: Rat
• Gene ID - Human:

  3417

• Formulation: 1 mg/mL in PBS containing 50% glycerol. No preservative is contained.

Citations for Anti-IDH1 (Human) mAb (Clone: RcMab-1) – 6 Found

Kaneko, Mika Kato; Tsujimoto, Yuta; Hozumi, Yasukazu; Goto, Kaoru; Kato, Yukinari. Novel monoclonal antibodies GMab-r1 and LMab-1 specifically recognize IDH1-R132G and IDH1-R132L mutations. Monoclonal Antibodies In Immunodiagnosis And Immunotherapy. 2013;32(3):224-8. 
- Comments: Used in: WB

Kaneko, Mika Kato; Tsujimoto, Yuta; Hozumi, Yasukazu; Goto, Kaoru; Kato, Yukinari. Novel monoclonal antibodies GMab-r1 and LMab-1 specifically recognize IDH1-R132G and IDH1-R132L mutations. Monoclonal Antibodies In Immunodiagnosis And Immunotherapy. 2013;32(3):224-8. 
- Comments: Used in: ICC

Kato, Yukinari; Natsume, Atsushi; Kaneko, Mika Kato. A novel monoclonal antibody GMab-m1 specifically recognizes IDH1-R132G mutation. Biochemical And Biophysical Research Communications. 2013;432(4):564-7. 
- Comments: Used in: WB

Ogasawara, Satoshi; Kaneko, Mika Kato; Tsujimoto, Yuta; Liu, Xing; Kato, Yukinari. Multi-specific monoclonal antibody MsMab-2 recognizes IDH1-R132L and IDH2-R172M mutations. Monoclonal Antibodies In Immunodiagnosis And Immunotherapy. 2013;32(6):377-81. 
- Comments: Used in: WB

Liu, Xing; Kato, Yukinari; Kaneko, Mika Kato; Sugawara, Masato; Ogasawara, Satoshi; Tsujimoto, Yuta; Naganuma, Yasushi; Yamakawa, Mitsunori; Tsuchiya, Takashi; Takagi, Michiaki. Isocitrate dehydrogenase 2 mutation is a frequent event in osteosarcoma detected by a multi-specific monoclonal antibody MsMab-1. Cancer Medicine. 2013;2(6):803-14. 
- Comments: Used in: WB

Ikota, Hayato; Nobusawa, Sumihito; Arai, Hideo; Kato, Yukinari; Ishizawa, Keisuke; Hirose, Takanori; Yokoo, Hideaki. Evaluation of IDH1 status in diffusely infiltrating gliomas by immunohistochemistry using anti-mutant and wild type IDH1 antibodies. Brain Tumor Pathology. 2015;32(4):237-44. 
- Comments: Used in: IHC